SKI Market

A+| A| A-|

Indian Indices

Sensex

74,775.74 -1,092.06
( -1.44%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

66,385.32 1,692.20
(2.62%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Onyx Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

93585

INE0WVU01018

30.5601085

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ONYX

70.72

EPS(TTM)

Face Value()

Div & Yield %

Back

Procter & Gamble Health standalone net profit declines 14.64% in the December 2025 quarter

Feb 06,2026

Net profit of Procter & Gamble Health declined 14.64% to Rs 77.59 crore in the quarter ended December 2025 as against Rs 90.90 crore during the previous quarter ended December 2024. Sales rose 20.69% to Rs 373.86 crore in the quarter ended December 2025 as against Rs 309.77 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	373.86	309.77	21
OPM %	29.55	39.85	-
PBDT	114.72	127.24	-10
PBT	108.82	121.69	-11
NP	77.59	90.90	-15

74,775.74 -1,092.06 ( -1.44%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

66,385.32 1,692.20 (2.62%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)